LIXONDEL
LIVE

Serial Number

79384568

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 2, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LIXONDEL Trademark

Serial Number: 79384568 • Registration: 7518564

LIXONDEL is a trademark filed by NOVARTIS AG on October 2, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 2, 2023

Registration Date

October 1, 2024

Published for Opposition

July 16, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 1, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 1, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 16, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 26, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 7, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 7, 2024 TROA
REFUSAL PROCESSED BY IB
May 14, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 2, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 1, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 13, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 25, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jan 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 18, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 2, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 2, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 2, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 2, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 2, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 2, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Dec 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2023 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 12, 2023 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 7, 2023 REPR